Purchases and Sales Made in Q4 2021 in Design Therapeutics, Inc. (DSGN)
This table provides information about the institutional ownership of Design Therapeutics, Inc. (DSGN) during Q4 2021. The information is specifically focused on institutions that hold shares of Design Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Mar 22, 2023
Q4 2021
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-11.2K- 50.72% |
$153K - $239K
|
10.9K
$50.5K
|
|
|
Jun 21, 2023
Q4 2021
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-11.2K- 50.72% |
$153K - $239K
|
10.9K
$50.5K
|
|
|
Feb 14, 2022
Q4 2021
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-14.9KClosed |
$204K - $320K
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-100K- 10.47% |
$1.36M - $2.14M
|
856K
$3.98M
|
|
|
Feb 14, 2022
Q4 2021
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-236KClosed |
$3.22M - $5.05M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-661K- 45.64% |
$9.02M - $14.2M
|
788K
$3.66M
|